Alois A. Gratwohl
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Ruxolitinib for Chronic Graft-versus-Host Disease.
Journal: The New England journal of medicine
Published: October 20, 2021
Visions for a JACIE Quality Management System 4.0.
Journal: Bone marrow transplantation
Published: August 22, 2021
Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluations.
Journal: Journal of medical economics
Published: May 12, 2021
Conditioning intensity before allogeneic haematopoietic stem cell transplantation: a quality control audit.
Journal: British journal of haematology
Published: February 22, 2021
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
Journal: Leukemia
Published: September 11, 2020
Ruxolitinib for Acute Graft-versus-Host Disease.
Journal: The New England journal of medicine
Published: July 30, 2020
High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
Journal: Leukemia
Published: February 27, 2020
Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Journal: Bone marrow transplantation
Published: November 23, 2019
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Journal: Bone marrow transplantation
Published: August 21, 2019
Last Updated: 09/26/2026